Nuwellis Inc (NUWE)

$3.25 +0.22 (7.26%)
Market Cap 2.74M
Revenue (ttm) 8.74M
Net Income (ttm) -11.17M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -127.80%
Debt to Equity Ratio 0.00
Volume 42,000
Avg Vol 227,950
Day's Range N/A - N/A
Shares Out 903,000.00
Stochastic %K 48%
Beta 0.11
Analysts Strong Buy
Price Target $11.00

Company Profile

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and...

Industry: Medical Devices
Sector: Healthcare
Phone: 952 345 4200
Address:
12988 Valley View Road, Eden Prairie, United States
NUWE_to_the_moon
NUWE_to_the_moon Oct. 24 at 9:47 PM
$NUWE was grinding up in after hours until some iatch put a 5k shares on the ask at 3.31. Lift your ask and let her fly.
0 · Reply
NUWE_to_the_moon
NUWE_to_the_moon Oct. 24 at 4:54 PM
$NUWE loading up for the launch
0 · Reply
Nelsons93
Nelsons93 Oct. 24 at 2:35 PM
$AREB $BNBX.X $EONR $GNPX $NUWE
0 · Reply
MarketMasterMind
MarketMasterMind Oct. 24 at 1:40 PM
📈 Top 5 Charts — Estimated Probability of Making Money Ⓜ️ $AREB ⚡ Strong uptrend, high volume, bullish sentiment building. $GNPX 🔥 Biotech setup forming — breakout potential ahead. $NUWE 💪 Solid base forming, accumulation signs on the chart. $BNBX.X 🚀 High-risk/high-reward zone — but technicals improving. $EONR ⚡ Fresh momentum — could surprise with next leg up. Charts speak louder than hype. Study the setups. 📊 Ⓜ️
0 · Reply
MarketMasterMind
MarketMasterMind Oct. 24 at 10:19 AM
🚨 My Top 5 Charts 📈 Estimated Probability of Making Money 🏦 $AREB ⚡ Strong uptrend, high volume, bullish sentiment building. $GNPX 🔥 Biotech setup forming — breakout potential ahead. $NUWE 💪 Solid base forming, accumulation signs on the chart. $BNBX.X 🚀 High-risk/high-reward zone — but technicals improving. $EONR ⚡ Fresh momentum — could surprise with next leg up. Charts speak louder than hype. Study the setups. Ⓜ️
0 · Reply
MarketMasterMind
MarketMasterMind Oct. 24 at 10:06 AM
$NUWE loading here for double digits soon 🤑Ⓜ️
0 · Reply
MarketMasterMind
MarketMasterMind Oct. 24 at 10:05 AM
$NUWE 👀 Ⓜ️
0 · Reply
NovaFoster
NovaFoster Oct. 24 at 12:50 AM
$NUWE Micro float under 1M shares, sitting near its 52-week low. Company just secured new patents, NIH grants, and FDA clearance for its Aquadex and pediatric ultrafiltration systems. With catalysts ahead and a tiny float, even a small wave of volume could send it ripping.
0 · Reply
done84
done84 Oct. 23 at 4:46 PM
$NUWE Overvalued junk. 🖕🖕🖕
0 · Reply
NUWE_to_the_moon
NUWE_to_the_moon Oct. 23 at 4:22 PM
$NUWE Hit that ASSSSK!!!
0 · Reply
Latest News on NUWE
Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

Oct 23, 2025, 9:00 AM EDT - 2 days ago

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

Sep 30, 2025, 8:45 AM EDT - 25 days ago

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration

Sep 18, 2025, 9:00 AM EDT - 5 weeks ago

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment

Sep 17, 2025, 10:16 AM EDT - 5 weeks ago

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment

Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Sep 9, 2025, 9:00 AM EDT - 6 weeks ago

Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

Sep 4, 2025, 8:15 AM EDT - 7 weeks ago

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

Aug 21, 2025, 8:15 AM EDT - 2 months ago

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Aug 19, 2025, 8:15 AM EDT - 2 months ago

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Aug 15, 2025, 8:15 AM EDT - 2 months ago

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Nuwellis, Inc. (NUWE) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 2:37 PM EDT - 2 months ago

Nuwellis, Inc. (NUWE) Q2 2025 Earnings Call Transcript

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Aug 14, 2025, 8:15 AM EDT - 2 months ago

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

Aug 7, 2025, 8:15 AM EDT - 2 months ago

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

Aug 6, 2025, 8:15 AM EDT - 2 months ago

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

Aug 5, 2025, 8:15 AM EDT - 2 months ago

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

Nuwellis Stockholders Approve All Proposals at Special Meeting

Aug 4, 2025, 5:24 PM EDT - 2 months ago

Nuwellis Stockholders Approve All Proposals at Special Meeting

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Jul 23, 2025, 8:45 AM EDT - 3 months ago

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Jul 23, 2025, 8:15 AM EDT - 3 months ago

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

Jul 22, 2025, 8:15 AM EDT - 3 months ago

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

Jul 17, 2025, 7:35 AM EDT - 3 months ago

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation

Jul 15, 2025, 4:05 PM EDT - 3 months ago

Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation

Nuwellis Appoints John Erb as Chief Executive Officer

Jul 2, 2025, 8:15 AM EDT - 4 months ago

Nuwellis Appoints John Erb as Chief Executive Officer

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

Jun 10, 2025, 4:15 PM EDT - 4 months ago

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

Jun 9, 2025, 9:15 AM EDT - 4 months ago

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

Nuwellis, Inc. (NUWE) Q1 2025 Earnings Call Transcript

May 13, 2025, 10:50 AM EDT - 5 months ago

Nuwellis, Inc. (NUWE) Q1 2025 Earnings Call Transcript

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

May 13, 2025, 7:00 AM EDT - 5 months ago

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

May 12, 2025, 7:00 AM EDT - 5 months ago

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

May 8, 2025, 7:00 AM EDT - 6 months ago

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

Apr 24, 2025, 7:00 AM EDT - 6 months ago

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

Apr 22, 2025, 4:05 PM EDT - 6 months ago

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

Nuwellis, Inc. (NUWE) Q4 2024 Earnings Call Transcript

Mar 11, 2025, 12:23 PM EDT - 8 months ago

Nuwellis, Inc. (NUWE) Q4 2024 Earnings Call Transcript

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

Mar 11, 2025, 8:00 AM EDT - 8 months ago

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO

Feb 24, 2025, 4:05 PM EST - 8 months ago

Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO

JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis

Feb 20, 2025, 8:00 AM EST - 8 months ago

JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

Feb 18, 2025, 4:15 PM EST - 8 months ago

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

Nuwellis, Inc. (NUWE) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 11:02 AM EST - 1 year ago

Nuwellis, Inc. (NUWE) Q3 2024 Earnings Call Transcript

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

Nov 11, 2024, 8:00 AM EST - 1 year ago

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

Nov 5, 2024, 9:28 AM EST - 1 year ago

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Nov 4, 2024, 8:30 AM EST - 1 year ago

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Nuwellis Announces Preliminary Results for Third Quarter of 2024

Nov 1, 2024, 4:15 PM EDT - 1 year ago

Nuwellis Announces Preliminary Results for Third Quarter of 2024

Nuwellis Welcomes University of Iowa Health Care Stead Family Children's Hospital as Newest Pediatric Customer

Oct 31, 2024, 8:00 AM EDT - 1 year ago

Nuwellis Welcomes University of Iowa Health Care Stead Family Children's Hospital as Newest Pediatric Customer

Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024

Oct 23, 2024, 4:15 PM EDT - 1 year ago

Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024

Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference

Sep 25, 2024, 4:15 PM EDT - 1 year ago

Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference

Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Aug 23, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Nuwellis, Inc. (NUWE) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 12:39 PM EDT - 1 year ago

Nuwellis, Inc. (NUWE) Q2 2024 Earnings Call Transcript

Nuwellis, Inc. Announces Second Quarter 2024 Financial Results

Aug 13, 2024, 8:00 AM EDT - 1 year ago

Nuwellis, Inc. Announces Second Quarter 2024 Financial Results

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical's QUELIMMUNE™ Therapy at Cincinnati Children's

Jul 26, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical's QUELIMMUNE™ Therapy at Cincinnati Children's

Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules

Jul 24, 2024, 8:02 AM EDT - 1 year ago

Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules

Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024

Jul 23, 2024, 4:10 PM EDT - 1 year ago

Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children's

Jul 17, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children's

Nuwellis Announces Reverse Stock Split

Jun 26, 2024, 8:45 AM EDT - 1 year ago

Nuwellis Announces Reverse Stock Split

NUWE_to_the_moon
NUWE_to_the_moon Oct. 24 at 9:47 PM
$NUWE was grinding up in after hours until some iatch put a 5k shares on the ask at 3.31. Lift your ask and let her fly.
0 · Reply
NUWE_to_the_moon
NUWE_to_the_moon Oct. 24 at 4:54 PM
$NUWE loading up for the launch
0 · Reply
Nelsons93
Nelsons93 Oct. 24 at 2:35 PM
$AREB $BNBX.X $EONR $GNPX $NUWE
0 · Reply
MarketMasterMind
MarketMasterMind Oct. 24 at 1:40 PM
📈 Top 5 Charts — Estimated Probability of Making Money Ⓜ️ $AREB ⚡ Strong uptrend, high volume, bullish sentiment building. $GNPX 🔥 Biotech setup forming — breakout potential ahead. $NUWE 💪 Solid base forming, accumulation signs on the chart. $BNBX.X 🚀 High-risk/high-reward zone — but technicals improving. $EONR ⚡ Fresh momentum — could surprise with next leg up. Charts speak louder than hype. Study the setups. 📊 Ⓜ️
0 · Reply
MarketMasterMind
MarketMasterMind Oct. 24 at 10:19 AM
🚨 My Top 5 Charts 📈 Estimated Probability of Making Money 🏦 $AREB ⚡ Strong uptrend, high volume, bullish sentiment building. $GNPX 🔥 Biotech setup forming — breakout potential ahead. $NUWE 💪 Solid base forming, accumulation signs on the chart. $BNBX.X 🚀 High-risk/high-reward zone — but technicals improving. $EONR ⚡ Fresh momentum — could surprise with next leg up. Charts speak louder than hype. Study the setups. Ⓜ️
0 · Reply
MarketMasterMind
MarketMasterMind Oct. 24 at 10:06 AM
$NUWE loading here for double digits soon 🤑Ⓜ️
0 · Reply
MarketMasterMind
MarketMasterMind Oct. 24 at 10:05 AM
$NUWE 👀 Ⓜ️
0 · Reply
NovaFoster
NovaFoster Oct. 24 at 12:50 AM
$NUWE Micro float under 1M shares, sitting near its 52-week low. Company just secured new patents, NIH grants, and FDA clearance for its Aquadex and pediatric ultrafiltration systems. With catalysts ahead and a tiny float, even a small wave of volume could send it ripping.
0 · Reply
done84
done84 Oct. 23 at 4:46 PM
$NUWE Overvalued junk. 🖕🖕🖕
0 · Reply
NUWE_to_the_moon
NUWE_to_the_moon Oct. 23 at 4:22 PM
$NUWE Hit that ASSSSK!!!
0 · Reply
Russell007xx
Russell007xx Oct. 23 at 4:19 PM
$NUWE under 2 by the end of November and then under 1 by December and then another Rs
0 · Reply
Russell007xx
Russell007xx Oct. 23 at 4:03 PM
$NUWE haha under 3
0 · Reply
NUWE_to_the_moon
NUWE_to_the_moon Oct. 23 at 3:37 PM
$NUWE Yawnn waiting for that pop back to $15-$20 range. Ridiculous these NUWE clowns didn't have a catalyst ready when this had a strong bounce back to $4.X two weeks ago.
0 · Reply
storkuk
storkuk Oct. 23 at 1:41 PM
$NUWE ER on 12 November
0 · Reply
NUWE_to_the_moon
NUWE_to_the_moon Oct. 23 at 1:28 PM
$NUWE
0 · Reply
done84
done84 Oct. 23 at 10:35 AM
$NUWE ATL and further dilution coming. Junk. 🖕🖕🖕
0 · Reply
done84
done84 Oct. 22 at 2:34 PM
$NUWE 52w high $175.98 😅🖕🖕
0 · Reply
Russell007xx
Russell007xx Oct. 22 at 11:58 AM
$NUWE 40 yet? lol I was waiting for 40 😆
1 · Reply
done84
done84 Oct. 22 at 11:54 AM
$NUWE When $40? Scam. 🖕🖕
0 · Reply
RachellePerson848
RachellePerson848 Oct. 21 at 4:55 PM
$NUWE improving recovery; AITX improving efficiency — strong quarter highlights real strategic execution.
1 · Reply
done84
done84 Oct. 21 at 2:15 PM
$NUWE endless toxic dilution!🖕🖕
0 · Reply
MissHollandia
MissHollandia Oct. 20 at 11:08 PM
$MSPR $CISS $NUWE $SGBX These stock won't stay cheap!
0 · Reply